MinuteCE®
A robust collection of short-form, digestible CE activities that are made to fit into any schedule. With MinuteCE, you’re in control of the content you want, when you want it. To start microlearning, follow these simple steps:
Step 1: Select the episodes & 1-minute challenges you'd like to consume
Step 2: Bank time as you blaze your way through the program
Step 3: Claim credit once available as shown in the Progress Bar
Step 4: Track the status of credits claimed in your profile
Why choose microlearning?
- Bite-sized episodes
- The most relevant content
- Improved retention
To experience MinuteCE for yourself, select one of the episodes below to start learning!
Episodes 376-390 of 455
Not All Therapy Needs to Be Swallowed or Injected: The Future of Digital Therapeutics to Alleviate the Negative Symptoms of Schizophrenia
MinuteCE®Not All Therapy Needs to Be Swallowed or Injected: The Future of Digital Therapeutics to Alleviate the Negative Symptoms of Schizophrenia
CIAS Effects on Patients and Caregivers: What Is the Personal and Economic Burden Caused by CIAS?
MinuteCE®CIAS Effects on Patients and Caregivers: What Is the Personal and Economic Burden Caused by CIAS?
ACC 2024: What's Really New in Electrophysiology That Will Change My Practice?
MinuteCE®ACC 2024: What's Really New in Electrophysiology That Will Change My Practice?
Integration Is the Key to Success: How Will the New SCZ Therapies Fit Into Clinical Treatment Paradigms?
MinuteCE®Integration Is the Key to Success: How Will the New SCZ Therapies Fit Into Clinical Treatment Paradigms?
Understanding CIAS: What Does Current Literature Say About the Etiology and Pathophysiology of CIAS?
MinuteCE®Understanding CIAS: What Does Current Literature Say About the Etiology and Pathophysiology of CIAS?
Staying Current: What Do Recent Clinical Trial Data Say About the New and Emerging Treatment Options for CIAS?
MinuteCE®Staying Current: What Do Recent Clinical Trial Data Say About the New and Emerging Treatment Options for CIAS?
Navigating Treatment-Related Adverse Effects in LAG-3 Combination ICI Therapy for Metastatic Melanoma
MinuteCE®Navigating Treatment-Related Adverse Effects in LAG-3 Combination ICI Therapy for Metastatic Melanoma
Patient Case: Tailoring First-Line Treatment for a Patient With Metastatic Melanoma and Impaired Performance Status
MinuteCE®Patient Case: Tailoring First-Line Treatment for a Patient With Metastatic Melanoma and Impaired Performance Status
Managing Immunotherapy-Related Adverse Events during Adjuvant Treatment for Resectable Melanoma
MinuteCE®Managing Immunotherapy-Related Adverse Events during Adjuvant Treatment for Resectable Melanoma
What Dermatologists & Surgeons Need To Know: Adjuvant Treatment for Resectable Stage II Melanoma
MinuteCE®What Dermatologists & Surgeons Need To Know: Adjuvant Treatment for Resectable Stage II Melanoma
Analyzing Key Data from LAG-3 Combinations in the Treatment of Metastatic Melanoma
MinuteCE®Analyzing Key Data from LAG-3 Combinations in the Treatment of Metastatic Melanoma
Unlocking Synergy: Exploring the Interaction Between LAG-3 and Other Immune Checkpoints
MinuteCE®Unlocking Synergy: Exploring the Interaction Between LAG-3 and Other Immune Checkpoints
